Assess whether the carve-out is operable on day one (dc7f22)

SITUATION A health-system acquiring a specialty practice cannot treat a TSA that expires before replacement systems exist as incidental context on customer concentration and termination-for-convenience clauses. Buy-side QoE lead must close the carve-out is operable from that extract under M&A Due Diligence / Legal, IP, and Regulatory.

DECISION Buy-side QoE lead in a health-system acquiring a specialty practice must choose Proceed / Reprice / Walk / Hold using customer concentration and termination-for-convenience clauses after a TSA that expires before replacement systems exist.

HYPOTHESES TO TEST 1. Authorize Proceed now; customer concentration and termination-for-convenience clauses already has the discriminator after a TSA that expires before replacement systems exist. 2. Keep Reprice in force until customer concentration and termination-for-convenience clauses is completed after a TSA that expires before replacement systems exist for buy-side QoE lead. 3. Treat customer concentration and termination-for-convenience clauses as Walk because both readings appear after a TSA that expires before replacement systems exist. 4. Refuse a M&A Due Diligence close: buy-side QoE lead does not have the decision the carve-out is operable turns on in customer concentration and termination-for-convenience clauses.

ANALYSIS REQUIRED 1. Separate a one-off add-back from a recurring earnings issue in customer concentration and termination-for-convenience clauses. 2. Map reps, earnout mechanics, and integration risk a health-system acquiring a specialty practice would inherit. 3. Tie quality-of-earnings, working-capital, and contingent items in customer concentration and termination-for-convenience clauses to the carve-out is operable. 4. For this M&A Due Diligence Legal, IP, and Regulatory file, read customer concentration and termination-for-convenience clauses against a TSA that expires before replacement systems exist and write the one fact that would move the carve-out is operable for buy-side QoE lead.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (customer concentration and termination-for-convenience clauses after a TSA that expires before replacement systems exist). The follow-on Legal, IP, and Regulatory action is what buy-side QoE lead does next: implement the option, assign an owner, and log the missing fact.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on the carve-out is operable, then the evidence in customer concentration and termination-for-convenience clauses, then the action for buy-side QoE lead - Hypothesis scorecard against customer concentration and termination-for-convenience clauses: supported / rejected / untestable - What changes the carve-out is operable if a TSA that expires before replacement systems exist is later withdrawn - Named option among Proceed, Reprice, Walk and the fact that kills the others